BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26056188)

  • 21. Association of Atrial Fibrillation and Stroke: Analysis of Maccabi Health Services Cardiovascular Database.
    Shames J; Weitzman S; Nechemya Y; Porath A
    Isr Med Assoc J; 2015 Aug; 17(8):486-91. PubMed ID: 26394490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation: a primary care cross-sectional study.
    Mashal A; Katz A; Shvartzman P
    Isr Med Assoc J; 2011 Nov; 13(11):666-71. PubMed ID: 22279699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.
    Fenger-Grøn M; Vestergaard CH; Ribe AR; Johnsen SP; Frost L; Sandbæk A; Davydow DS
    JAMA Netw Open; 2021 May; 4(5):e2110096. PubMed ID: 33999163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
    Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
    Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. South Asian ethnicity is associated with a lower prevalence of atrial fibrillation despite greater prevalence of established risk factors: a population-based study in Bradford Metropolitan District.
    Gillott RG; Willan K; Kain K; Sivananthan UM; Tayebjee MH
    Europace; 2017 Mar; 19(3):356-363. PubMed ID: 26941337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort.
    Yavuz B; Ata N; Oto E; Katircioglu-Öztürk D; Aytemir K; Evranos B; Koselerli R; Ertugay E; Burkan A; Ertugay E; Gale CP; Camm AJ; Oto A
    Europace; 2017 May; 19(5):734-740. PubMed ID: 28186565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of atrial fibrillation on postoperative outcomes after total knee arthroplasty-A retrospective study.
    Long G; Suqin S; Li G; Weihong Y; Zhenhu W
    J Orthop Sci; 2016 Sep; 21(5):652-7. PubMed ID: 27324666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants.
    Alqarawi W; Birnie DH; Spence S; Ramirez FD; Redpath CJ; Lemery R; Nair GM; Nery PB; Davis DR; Green MS; Beauchesne L; Chan K; Ascah K; Burwash I; Sadek MM
    Europace; 2019 Jan; 21(1):48-53. PubMed ID: 29897439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of ischemic stroke and atrial fibrillation in young patients with migraine national inpatient sample analysis.
    Kuybu O; Amireh A; Davis D; Kelley RE; Javalkar V
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104972. PubMed ID: 32689612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.
    Sudlow M; Thomson R; Thwaites B; Rodgers H; Kenny RA
    Lancet; 1998 Oct; 352(9135):1167-71. PubMed ID: 9777832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of baseline characteristics and risk factors among Emergency Department patients presenting with recent onset atrial fibrillation: a retrospective cohort study.
    Buccelletti F; Di Somma S; Iacomini P; Galante A; Pugliese F; Alegiani F; Bertazzoni G; Marsiliani D; Carroccia A; Granato A; Calabrò G; Legramante JM; Zuccalà G; Franceschi F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():22-7. PubMed ID: 23436662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study.
    Bardai A; Blom MT; van Hoeijen DA; van Deutekom HW; Brouwer HJ; Tan HL
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1033-9. PubMed ID: 25236735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of atrial fibrillation in Greenland: a register-based cross-sectional study based on disease classifications and prescriptions of oral anticoagulants.
    Albertsen N; Riahi S; Pedersen ML; Skovgaard N; Andersen S
    Int J Circumpolar Health; 2022 Dec; 81(1):2030522. PubMed ID: 35086441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    Königsbrügge O; Posch F; Antlanger M; Kovarik J; Klauser-Braun R; Kletzmayr J; Schmaldienst S; Auinger M; Zuntner G; Lorenz M; Grilz E; Stampfel G; Steiner S; Pabinger I; Säemann M; Ay C
    PLoS One; 2017; 12(1):e0169400. PubMed ID: 28052124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF).
    Vinereanu D; Al-Khalidi HR; Rao MP; He W; Lopes RD; Bahit CM; Ciobanu AO; Fox KA; Pokorney SD; Xian Y; Jiang J; Kamath DY; Berwanger O; Tajer C; Huo Y; Xavier D; Granger CB
    Am Heart J; 2017 Oct; 192():38-47. PubMed ID: 28938962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
    Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
    Opolski G; Kosior DA; Kurzelewski M; Skrzyńska M; Zagórski A; Janion M; Muzolf M; Wlazłowski R; Pankiewicz B; Łoboz-Grudzień K; Breithardt G;
    Kardiol Pol; 2010 May; 68(5):546-54. PubMed ID: 20491018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
    Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
    BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.